<?xml version="1.0" encoding="UTF-8"?>
<ref id="b64-ol-0-0-12525">
 <label>64</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Dong</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Song</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Wu</surname>
    <given-names>X</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>W</given-names>
   </name>
  </person-group>
  <article-title>NOL6, a new founding oncogene in human prostate cancer and targeted by miR-590-3p</article-title>
  <source>Cytotechnology</source>
  <volume>72</volume>
  <fpage>469</fpage>
  <lpage>478</lpage>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1007/s10616-020-00394-8</pub-id>
  <?supplied-pmid 32249364?>
  <pub-id pub-id-type="pmid">32249364</pub-id>
 </element-citation>
</ref>
